Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Infobox
Patent Citations
‌
US Patent 10023800 Composition for manufacturing optical elements with negative optical dispersion, and optically anisotropic body manufactured therefrom
0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
NiKang Therapeutics, Inc.
0
Current Assignee
‌
NiKang Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114593400
Date of Patent
October 4, 2022
0
Patent Application Number
172772930
Date Filed
September 17, 2019
0
Patent Citations
‌
US Patent 10017520 Myc modulators and uses thereof
0
‌
US Patent 10023800 Composition for manufacturing optical elements with negative optical dispersion, and optically anisotropic body manufactured therefrom
0
‌
US Patent 10069079 Organic electroluminescent device with thermally activated delayed fluorescence material
0
‌
US Patent 10072017 Compounds and methods for the treatment of cystic fibrosis
0
‌
US Patent 10076581 Deuterated compounds and uses thereof
0
‌
US Patent 10087151 Substituted benzoxazine and related compounds
0
‌
US Patent 10120281 Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank provided with actinic ray-sensitive or radiation-sensitive film, photomask, pattern forming method, method for manufacturing electronic device, and electronic device
0
‌
US Patent 10125126 N-cycloalkyl-N-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
0
‌
US Patent 10131841 Liquid-crystalline medium
0
‌
US Patent 10164200 Organometallic compound and organic light-emitting device including the same
0
‌
US Patent 10180626 Sulfonium salt, resist composition, and patterning process
0
‌
US Patent 10199583 Blue luminescent material of platinum complex and organic light-emitting device
0
‌
US Patent 10201531 Indazolyl-oxo-isothiazole compounds
0
‌
US Patent 10205190 Composite electrolyte including polymeric ionic liquid and inorganic particles and lithium battery including the same
0
‌
US Patent 10240085 Thin film and organic light-emitting device including the same
0
‌
US Patent 10243149 Composition, thin film including the composition, and organic light-emitting device including the composition or the thin film
0
‌
US Patent 10280171 Heterocyclic inhibitors of PTPN11
0
‌
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
‌
US Patent 10336772 Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
0
‌
US Patent 10376594 Bio-orthogonal drug activation
0
‌
US Patent 10435369 Tricyclic sulfones as ROR gamma modulators
0
‌
US Patent 10463661 Anthelmintic compounds
0
‌
US Patent 10478445 Boronic acid derivatives of resveratrol for activating deacetylase enzymes
0
‌
US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
0
‌
US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
0
Patent Primary Examiner
‌
Charanjit Aulakh
0
CPC Code
‌
C07D 401/14
0
‌
C07D 498/14
0
‌
A61P 35/00
0
‌
A61K 31/5383
0
‌
A61K 31/497
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Edits on 20 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 20 Mar, 2023
Edits on 8 Oct, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 8 Oct, 2022
Edits made to:
Infobox (+39 properties)
Article (+336 characters)
‌

 US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Article

The present disclosure provides certain tri-substituted heteroaryl derivatives that are Src Homology-2 phosphatase (SHP2) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of SHP2. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
NiKang Therapeutics, Inc.
0
Current Assignee
‌
NiKang Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114593400
Date of Patent
October 4, 2022
0
Patent Application Number
172772930
Date Filed
September 17, 2019
0
Patent Citations
‌
US Patent 10017520 Myc modulators and uses thereof
0
‌
US Patent 10023800 Composition for manufacturing optical elements with negative optical dispersion, and optically anisotropic body manufactured therefrom
0
‌
US Patent 10069079 Organic electroluminescent device with thermally activated delayed fluorescence material
0
‌
US Patent 10072017 Compounds and methods for the treatment of cystic fibrosis
0
‌
US Patent 10076581 Deuterated compounds and uses thereof
0
‌
US Patent 10087151 Substituted benzoxazine and related compounds
0
‌
US Patent 10120281 Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank provided with actinic ray-sensitive or radiation-sensitive film, photomask, pattern forming method, method for manufacturing electronic device, and electronic device
0
‌
US Patent 10125126 N-cycloalkyl-N-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
0
‌
US Patent 10131841 Liquid-crystalline medium
0
‌
US Patent 10164200 Organometallic compound and organic light-emitting device including the same
0
‌
US Patent 10180626 Sulfonium salt, resist composition, and patterning process
0
‌
US Patent 10199583 Blue luminescent material of platinum complex and organic light-emitting device
0
‌
US Patent 10201531 Indazolyl-oxo-isothiazole compounds
0
‌
US Patent 10205190 Composite electrolyte including polymeric ionic liquid and inorganic particles and lithium battery including the same
0
‌
US Patent 10240085 Thin film and organic light-emitting device including the same
0
‌
US Patent 10243149 Composition, thin film including the composition, and organic light-emitting device including the composition or the thin film
0
‌
US Patent 10280171 Heterocyclic inhibitors of PTPN11
0
‌
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
0
‌
US Patent 10336772 Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
0
‌
US Patent 10376594 Bio-orthogonal drug activation
0
‌
US Patent 10435369 Tricyclic sulfones as ROR gamma modulators
0
‌
US Patent 10463661 Anthelmintic compounds
0
‌
US Patent 10478445 Boronic acid derivatives of resveratrol for activating deacetylase enzymes
0
‌
US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors
0
‌
US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
0
Patent Primary Examiner
‌
Charanjit Aulakh
0
CPC Code
‌
C07D 401/14
0
‌
C07D 498/14
0
‌
A61P 35/00
0
‌
A61K 31/5383
0
‌
A61K 31/497
0

Find more entities like US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo